secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2024-12-17T23:59:59+00:00
Accession:  0001628280-24-051683
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth appoints Stephen J. Fanning to Board; former Hydrafacial Chairman
------------------------------------------------------------------------------

- Stephen Fanning appointed to BeautyHealth board effective Dec 12, 2024; joins Audit & Nominating committees.
- Fanning served as Hydrafacial Chairman from 2016-2020 prior to its IPO; led Solta Medical (Thermage, Fraxel).
- Recent roles include CEO of Spectrum Solutions and Z-Medica; previously held senior roles at Johnson & Johnson.
- Board now has eight directors; Fanning qualifies as independent under Nasdaq rules.
- Compensation follows standard non-employee director package as disclosed in April 2024 proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024051683/0001628280-24-051683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828024051683/skin-20241212.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-051683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer